SWIFTWATER, Pa. and LYON, France, June 23 Sanofi Pasteur,the vaccines division of the sanofi-aventis Group, announced today that theU.S. Food and Drug Administration (FDA) has licensed Pentacel(R), ...
The vaccines unit of Sanofi-Aventis says that US regulators have given the green light to the firm’s new five-in-one paediatric jab Pentacel. The vaccines unit of Sanofi-Aventis says that US ...
Pentacel pediatric vaccine approved The FDA has approved Pentacel (DTaP/IPV/Hib vaccine, from sanofi pasteur) for active immunization of children from 6 weeks through 4 years of age against diphtheria ...
Pharmacologic class: Vaccine (diphtheria, tetanus, and pertussis [DTaP]-inactivated polio vaccine [IPV] + Hemophilus influenzae type b [Hib]/polysaccharide tetanus conjugate [PRP-T]) Active ...
PARIS, June 11 (Reuters) - The U.S. Food and Drug Administration has delayed giving a marketing decision on Sanofi-Pasteur's vaccine Pentacel until Nov. 2 from June 8, the French vaccine maker said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results